Recruiting
Outcomes of Focal Ablation for Prostate Cancer
About this study
This study will be designed to define the efficacy and safety of ablative therapies in the management of localized prostate cancer and comprehensively evaluate quality of life outcomes and oncologic control following treatment.
- Condition
- Prostate Cancer
- Sponsor
- University of Texas Southwestern Medical Center
Who can join
- Age
- 18 to 90 years
- Sex
- Male only
- Healthy volunteers
- Not accepted
Inclusion 9
- Minimum age: 18 years
- Maximum age: 90 years
- Eligible sex: Male
- Study condition: Prostate Cancer
- Men with histologically confirmed prostate adenocarcinoma diagnosed on prostate biopsy
- Men with histologically confirmed local recurrence of prostate cancer diagnosed on prostate biopsy and standard of care imaging excluding locoregional or metastatic disease
- Age 18-90 years.
- Life expectancy \> 1 year
- Ability to understand and the willingness to sign a written informed consent.
Exclusion 3
- Anatomic abnormalities that do not allow for focal ablation
- Evidence of non-organ confined disease that is not feasible for ablation
- Has active urinary traction infection
Where
1 site, 1 recruiting
UTSW
Dallas, Texas, United States
Contact
-
Sonobia Garrett
214/645-8482 Sonobia.Garrett@UTSouthwestern.edu
Potential match only. Final eligibility is determined by the study team.